David Rosenbaum - May 21, 2024 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Role
Chief Development Officer
Signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Rosenbaum
Stock symbol
ARDX
Transactions as of
May 21, 2024
Transactions value $
-$55,091
Form type
4
Date filed
5/23/2024, 04:19 PM
Previous filing
Feb 28, 2024
Next filing
Jun 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARDX Common Stock Sale -$37.9K -4.86K -1.27% $7.81 376K May 21, 2024 Direct F1, F2
transaction ARDX Common Stock Sale -$17.2K -2.2K -1.23% $7.81 176K May 21, 2024 By Wife F1, F3, F4
holding ARDX Common Stock 77.6K May 21, 2024 Family Trust F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.
F2 Reflects the adjusted total which includes the purchase of 2,349 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
F3 Reflects the adjusted total which includes the purchase of 2,636 shares under the Ardelyx Employee Stock Purchase Plan in February 2024.
F4 The shares are directly held by the Reporting Person's wife.
F5 The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.